Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Oncotarget
|
May 28, 2015
Clinical next generation sequencing to identify actionable aberrations in a phase I program
Genevieve M Boland, Sarina A Piha-Paul, Vivek Subbiah, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes
Jonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Molecular Cancer Therapeutics
|
December 15, 2017
Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer
Yan Huang, Wei Hu, Jie Huang, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Gynecologic Oncology
|
February 10, 2021
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer
Jean H Siedel, Kari L Ring, Wei Hu, et al.
Journal of the National Cancer Institute
|
April 12, 2015
A decision support framework for genomically informed investigational cancer therapy
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
Janos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib
Jie Huang, Wei Hu, Justin Bottsford-Miller, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Oncotarget
|
May 28, 2015
Clinical next generation sequencing to identify actionable aberrations in a phase I program
Genevieve M Boland, Sarina A Piha-Paul, Vivek Subbiah, et al.
Oncotarget
|
September 10, 2019
Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes
Jonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Molecular Cancer Therapeutics
|
December 15, 2017
Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer
Yan Huang, Wei Hu, Jie Huang, et al.
Oncotarget
|
April 19, 2017
A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
Natalia Paez Arango, Lauren Brusco, Kenna R Mills Shaw, et al.
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Gynecologic Oncology
|
February 10, 2021
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer
Jean H Siedel, Kari L Ring, Wei Hu, et al.
Journal of the National Cancer Institute
|
April 12, 2015
A decision support framework for genomically informed investigational cancer therapy
Funda Meric-Bernstam, Amber Johnson, Vijaykumar Holla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer
Janos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib
Jie Huang, Wei Hu, Justin Bottsford-Miller, et al.
Page
of 10